Introduction The field of hematology and oncology is one the fastest growing and ever-evolving fields in medicine. In the past decade, substantial improvements in the diagnosis, and more importantly, the treatment of various hematologic and oncologic malignances have led to…
Open full size image KEY POINTS Cancer survivors are at risk of developing arrhythmias, often not diagnosed until clinically evident, and at times with life-threatening consequences. The long-term risk of recurrent arrhythmias once in remission and after cessation of cancer…
Open full size image KEY POINTS Atrial fibrillation and other atrial arrhythmias are common complications of many different cancer therapeutics. The CHA 2 DS 2 -VASc and the HAS-BLED scores may not be appropriate to determine thromboembolic and bleeding risk…
Open full size image KEY POINTS All patients with cancer should be evaluated for the presence and risk of developing arrhythmias because these can significantly complicate treatments and outcomes The intake should include preexisting atrial fibrillation, QTc prolongation, and cardiac…